Equity, RSUs, and Options Explained for Non-Technical Executives

Restricted Stock Units are the dominant equity vehicle at public companies and late-stage startups. The concept sounds clean: the company promises to give you shares over time. You vest quarterly or monthly. You get shares. You sell shares. Done.

Except there are three things that make RSUs complicated, and all three cost executives real money when they're ignored.

The tax event happens at vesting, not at sale. When your RSUs vest, the market value of those shares on that exact day is treated as ordinary income. It doesn't matter that you planned to hold them. It doesn't matter that the stock dropped 30% the following week. You owe income tax on the value at vesting. Your company will withhold shares to cover the minimum required withholding - typically 22% federal for supplemental income - but if you're in a high bracket, you may owe significantly more at tax time.

The value at grant versus the value at vesting can be wildly different. A Director at a high-growth SaaS company in 2021 who got 1,000 RSUs when the stock was at $180 per share looked at $180,000 in equity. Two years later, when those shares vested in 2023, the stock was at $62. They received $62,000. Still money. Still not $180,000.

The cliff is where the risk actually sits. Standard vesting is four years with a one-year cliff. That means zero shares until twelve months in. If you leave at month eleven - for any reason - you walk away with nothing from that grant. Companies designed it this way deliberately. Know what you're signing.

One lever executives rarely negotiate: accelerated vesting. At the Director level and above, you have real standing to ask for accelerated vesting on acquisition - meaning if the company gets bought, your unvested shares vest immediately. This is called "double trigger" acceleration (termination plus acquisition trigger). Some companies offer it. Most won't bring it up. Ask anyway.

Equity percentages are almost meaningless without context. "Half a percent of the company" sounds like a lot. Half a percent of what, after how many funding rounds, with what liquidation preferences attached, is the real question.

The cap table is the document that shows who owns what. In a healthy pre-IPO deal, you want to understand the following before you accept:

• Current valuation and your entry price. If you're joining at a $500M valuation with a $1.50 strike price, the company needs to exit at materially higher for you to profit meaningfully on options.
• Liquidation preferences. Preferred investors (VCs) often have 1x or 2x liquidation preferences. This means they get paid first on exit - before common shareholders get anything. A $200M acquisition looks great until the preferred stack eats most of it.
• Participating preferred stock. Some VC agreements let investors take their liquidation preference AND participate in the remaining proceeds pro-rata. This is called "participating preferred" and it dramatically reduces common shareholder returns at moderate exit multiples.
• Dilution from future rounds. Ask how many authorized but unissued shares exist, and whether the company plans to raise again. Every new round dilutes your percentage. This is normal - but it should factor into how you value the grant today.
• 409A valuation versus preferred price. The 409A is the IRS-approved fair market value of common stock used to set your strike price. It's always lower than the preferred price paid by investors. A healthy ratio is 409A around 25-33% of the preferred price. If they're nearly equal, you're paying close to investor prices without investor protections.

Equity compensation creates tax complexity that compounds over time. This is not a guide to give you tax advice - that requires an accountant familiar with your jurisdiction. But here are the mechanics every executive should understand before signing.

RSU tax: ordinary income at vesting. The fair market value of your shares on the vesting date is added to your W-2 (or equivalent in your country). You pay income tax at your marginal rate. If you're in a high bracket - likely, if you're at the Director level and above - that can be 37% federal plus state. Your company will withhold some shares for taxes, but often not enough if you're in the top bracket. Set money aside for April.

ISO options: the AMT trap. ISOs sound like the best option because qualifying dispositions (hold for 1 year after exercise, 2 years after grant date) get long-term capital gains treatment. The problem: exercising ISOs creates an Alternative Minimum Tax (AMT) preference item equal to the spread between your strike price and the fair market value at exercise. If you exercise a large ISO grant and the stock then drops, you can owe AMT on gains you never actually received. This is what happened to thousands of employees after the 2000 dot-com crash. Know this risk before exercising ISOs in a volatile market.

NSO options: pay at exercise, pay again at sale. With non-qualified options, you owe ordinary income tax on the spread (market value minus strike price) when you exercise. Then when you sell, you owe capital gains tax on any appreciation from your exercise price. Hold more than a year after exercise and it's long-term capital gains rates. Less than a year, ordinary income rates again.

If you're outside the US: the tax treatment varies dramatically by country. RSUs in Japan are taxed as employment income at vesting, same as the US model, but the rates and brackets differ. In many EU countries, there are specific regimes for stock compensation that can either help or hurt depending on timing and holding period. If your company is US-listed and you're based internationally, you may also have reporting obligations in both countries. Get an advisor who handles cross-border equity compensation. It is not optional at these comp levels.

The strategic move most executives miss: coordinate your RSU vesting with other income events. If you're receiving a large bonus in Q4 and you have RSUs vesting in December, you're stacking income in one tax year. Sometimes deferring a vesting tranche or timing the sale of already-vested shares can meaningfully reduce your effective tax rate. These decisions require planning - not panic at tax time.